| Revenue growth | Value |
|---|---|
| 1Y (TTM) | +29% |
| 3Y CAGR | +3% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | +139% |
| 3Y CAGR | +4% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
PfizerPFIZER | ₹4,978.20 +58.20 (1.18%) | 22,759.95 | 30.96 | 5.42 | ||
Caplin Point LaboratoriesCAPLIPOINT | ₹2,560.80 +31.10 (1.23%) | 19,444.55 | 28.68 | 5.42 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹7,415.50 -91.50 (1.22%) | 18,526.25 | 109.22 | 21.23 | ||
Natco PharmaNATCOPHARM | ₹882.40 +4.90 (0.56%) | 15,806.45 | 13.81 | 1.71 |